Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Apoptosis Inducers
Apoptosis inducers exhibit pro-apoptotic effects through a variety of mechanisms, including DNA cross-linking, inhibition of antiapoptotic proteins and activation of caspases. These inducers may target a specific cellular process in order to induce antitumor or antineoplastic effects.
Apoptosis Inducing Products
Cat.No. |
Product Name / Activity |
| 1229 | Actinomycin D |
| Antineoplastic antibiotic | |
| 4846 |
Apicidin
|
| Histone deacetylase inhibitor; induces apoptosis | |
| 2098 | Apoptosis Activator 2 |
| Selectively induces tumor cell apoptosis | |
| 3367 | AT 101 |
| Downregulates Bcl-2 and Mcl-1; pro-apoptotic | |
| 4810 |
BAM 7
|
| Selective Bax activator; induces Bax-mediated apoptosis | |
| 3681 | Bendamustine hydrochloride |
| Cytostatic agent; exhibits DNA alkylating and purine analog properties | |
| 3906 | Betulinic acid |
| Antitumor and anti-HIV agent; activates NF-κB. Also TGR5 agonist | |
| 2489 | C 75 |
| Induces apoptosis and exhibits anti-tumor activity | |
| 2626 | Carboplatin |
| DNA cross-linking antitumor agent | |
| 3868 | CHM 1 |
| Potent antitumor agent; inducer of apoptosis | |
| 2251 | Cisplatin |
| DNA-alkylating antitumor agent | |
| 2841 | Curcumin |
| Antitumor, anti-inflammatory and antioxidant | |
| 4091 | Cyclophosphamide |
| Alkylating agent; chemotherapeutic | |
| 2137 | 2,3-DCPE hydrochloride |
| Selectively induces cancer cell apoptosis | |
| 1770 | Deguelin |
| Anticancer and antiviral agent; chemopreventive and pro-apoptotic | |
| 2252 | Doxorubicin hydrochloride |
| Antitumor antibiotic agent; induces apoptosis | |
| 3495 | Fludarabine |
| Proapoptotic; increases Bax and decreases Bid, XIAP and survivin expression | |
| 3590 | Gambogic acid |
| Apoptosis inducer. Activates caspases and inhibits Bcl-2 family proteins | |
| 3603 | Kaempferol |
| Proapoptotic; downregulates PLK1 expression and activates mitochondrial Ca2+ uniporter | |
| 1807 | 2-Methoxyestradiol |
| Apoptotic and antiangiogenic agent | |
| 3258 | Mitomycin C |
| DNA cross-linking antitumor agent | |
| 3715 | Narciclasine |
| Antiproliferative agent; exhibits pro-apoptotic effects | |
| 3427 | Oncrasin 1 |
| Proapoptotic; induces abnormal nuclear accumulation of PKCι | |
| 2623 | Oxaliplatin |
| DNA cross-linking antitumor agent | |
| 4396 | Piperlongumine |
| Induces apoptosis; increases p53 and ROS levels in cancer cells | |
| 4761 |
Plumbagin
|
| Induces apoptosis; anticancer | |
| 1621 | Streptozocin |
| DNA alkylator; antitumor and induces diabetes | |
| 2706 | Temozolomide |
| DNA-methylating antitumor agent | |
| 4038 | TW 37 |
| Bcl-2 inhibitor; induces apoptosis | |
Quick Order
Find multiple products by catalog number
Tocris Events
Win a Kindle
5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders
June 23 - 26, 2013
Bath, UK





